Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 31, 2019

SELL
$72.81 - $156.91 $449,965 - $969,703
-6,180 Closed
0 $0
Q1 2019

Nov 14, 2019

BUY
$106.67 - $151.68 $659,220 - $937,382
6,180 New
6,180 $737,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Orser Capital Management, LLC Portfolio

Follow Orser Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orser Capital Management, LLC with notifications on news.